• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种与全面发育迟缓及持续性小脑功能障碍相关的新型KCNA1突变。

A novel KCNA1 mutation associated with global delay and persistent cerebellar dysfunction.

作者信息

Demos Michelle K, Macri Vincenzo, Farrell Kevin, Nelson Tanya N, Chapman Kristine, Accili Eric, Armstrong Linlea

机构信息

Department of Pediatric Neurology, British Columbia's Children's Hospital, Vancouver, British Columbia, Canada.

出版信息

Mov Disord. 2009 Apr 15;24(5):778-82. doi: 10.1002/mds.22467.

DOI:10.1002/mds.22467
PMID:19205071
Abstract

Episodic Ataxia Type 1 is an autosomal dominant disorder characterized by episodes of ataxia and myokymia. It is associated with mutations in the KCNA1 voltage-gated potassium channel gene. In the present study, we describe a family with novel clinical features including persistent cerebellar dysfunction, cerebellar atrophy, and cognitive delay. All affected family members have myokymia and epilepsy, but only one individual has episodes of vertigo. Additional features include postural abnormalities, episodic stiffness and weakness. A novel KCNA1 mutation (c.1222G>T) which replaces a highly conserved valine with leucine at position 408 (p.Val408Leu) was identified in affected family members, and was found to augment the ability of the channel to inactivate. Together, our data suggests that KCNA1 mutations are associated with a broader clinical phenotype, which may include persistent cerebellar dysfunction and cognitive delay.

摘要

1型发作性共济失调是一种常染色体显性疾病,其特征为共济失调发作和肌纤维颤搐。它与KCNA1电压门控钾通道基因突变有关。在本研究中,我们描述了一个具有新临床特征的家系,包括持续性小脑功能障碍、小脑萎缩和认知延迟。所有受影响的家庭成员都有肌纤维颤搐和癫痫,但只有一人有眩晕发作。其他特征包括姿势异常、发作性僵硬和虚弱。在受影响的家庭成员中鉴定出一种新的KCNA1突变(c.1222G>T),该突变在第408位将高度保守的缬氨酸替换为亮氨酸(p.Val408Leu),并发现其增强了通道失活的能力。总之,我们的数据表明KCNA1突变与更广泛的临床表型相关,这可能包括持续性小脑功能障碍和认知延迟。

相似文献

1
A novel KCNA1 mutation associated with global delay and persistent cerebellar dysfunction.一种与全面发育迟缓及持续性小脑功能障碍相关的新型KCNA1突变。
Mov Disord. 2009 Apr 15;24(5):778-82. doi: 10.1002/mds.22467.
2
Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability.钾通道基因KCNA1突变的临床、遗传及表达研究揭示了新的表型变异性。
Ann Neurol. 2000 Oct;48(4):647-56.
3
A novel mutation in KCNA1 causes episodic ataxia without myokymia.KCNA1基因的一种新突变导致无肌纤维颤搐的发作性共济失调。
Hum Mutat. 2004 Dec;24(6):536. doi: 10.1002/humu.9295.
4
Novel mutation in KCNA1 causes episodic ataxia with paroxysmal dyspnea.KCNA1基因的新型突变导致发作性共济失调伴阵发性呼吸困难。
Muscle Nerve. 2008 Mar;37(3):399-402. doi: 10.1002/mus.20904.
5
Expanding the phenotype of potassium channelopathy: severe neuromyotonia and skeletal deformities without prominent Episodic Ataxia.扩大钾通道病的表型:严重的神经性肌强直和骨骼畸形,无明显发作性共济失调。
Neuromuscul Disord. 2004 Oct;14(10):689-93. doi: 10.1016/j.nmd.2004.06.007.
6
Episodic ataxia and myokymia syndrome: a new mutation of potassium channel gene Kv1.1.发作性共济失调伴肌纤维颤搐综合征:钾通道基因Kv1.1的一种新突变。
Ann Neurol. 1996 Oct;40(4):684-7. doi: 10.1002/ana.410400422.
7
Predominant dystonia with marked cerebellar atrophy: a rare phenotype in familial dystonia.以显著小脑萎缩为主的肌张力障碍:家族性肌张力障碍中的一种罕见表型。
Neurology. 2006 Nov 28;67(10):1769-73. doi: 10.1212/01.wnl.0000244484.60489.50.
8
Episodic ataxia type 1 with distal weakness: a novel manifestation of a potassium channelopathy.伴有远端肌无力的发作性共济失调1型:一种钾通道病的新表现
Neuropediatrics. 2004 Apr;35(2):147-9. doi: 10.1055/s-2004-817921.
9
Functional analysis of a novel potassium channel (KCNA1) mutation in hereditary myokymia.遗传性肌束震颤中一种新型钾通道(KCNA1)突变的功能分析。
Neurogenetics. 2007 Apr;8(2):131-5. doi: 10.1007/s10048-006-0071-z. Epub 2006 Nov 29.
10
Dominant-negative mutation p.Arg324Thr in KCNA1 impairs Kv1.1 channel function in episodic ataxia.KCNA1基因中的显性负性突变p.Arg324Thr损害发作性共济失调中的Kv1.1通道功能。
Mov Disord. 2016 Nov;31(11):1743-1748. doi: 10.1002/mds.26737. Epub 2016 Aug 1.

引用本文的文献

1
Novel Genetic Variants Expand the Functional, Molecular, and Pathological Diversity of Channelopathy.新型遗传变异扩大了通道病的功能、分子和病理多样性。
Int J Mol Sci. 2023 May 16;24(10):8826. doi: 10.3390/ijms24108826.
2
Cervical Dystonia with Cerebellar Ataxia in KCNA1 Mutation: A Phenotypic Expansion.KCNA1 突变所致伴有小脑共济失调的颈部肌张力障碍:一种表型扩展
Ann Indian Acad Neurol. 2022 Sep-Oct;25(5):942-944. doi: 10.4103/aian.aian_235_22. Epub 2022 May 5.
3
Clinical and Functional Study of a De Novo Variant in the PVP Motif of Kv1.1 Channel Associated with Epilepsy, Developmental Delay and Ataxia.
Kv1.1 通道 PVP 基序中新发变异与癫痫、发育迟缓伴共济失调的临床和功能研究。
Int J Mol Sci. 2022 Jul 22;23(15):8079. doi: 10.3390/ijms23158079.
4
A Common Kinetic Property of Mutations Linked to Episodic Ataxia Type 1 Studied in the Shaker Kv Channel.与发作性共济失调症 1 型相关突变的共同动力学特性在 Shaker Kv 通道中的研究。
Int J Mol Sci. 2020 Oct 14;21(20):7602. doi: 10.3390/ijms21207602.
5
Episodic Ataxias: Faux or Real?发作性共济失调:是真是假?
Int J Mol Sci. 2020 Sep 5;21(18):6472. doi: 10.3390/ijms21186472.
6
Two novel KCNA1 variants identified in two unrelated Chinese families affected by episodic ataxia type 1 and neurodevelopmental disorders.在两个无关联的中国家庭中发现的两个新型 KCNA1 变体,受发作性共济失调 1 型和神经发育障碍的影响。
Mol Genet Genomic Med. 2020 Oct;8(10):e1434. doi: 10.1002/mgg3.1434. Epub 2020 Jul 23.
7
Clinical and Genetic Overview of Paroxysmal Movement Disorders and Episodic Ataxias.发作性运动障碍和发作性共济失调的临床和遗传概述。
Int J Mol Sci. 2020 May 20;21(10):3603. doi: 10.3390/ijms21103603.
8
Kv1.1 Channelopathies: Pathophysiological Mechanisms and Therapeutic Approaches.Kv1.1 通道病:病理生理机制和治疗方法。
Int J Mol Sci. 2020 Apr 22;21(8):2935. doi: 10.3390/ijms21082935.
9
Clinical Spectrum of Mutations: New Insights into Episodic Ataxia and Epilepsy Comorbidity.突变的临床谱:对发作性共济失调和癫痫共病的新认识。
Int J Mol Sci. 2020 Apr 17;21(8):2802. doi: 10.3390/ijms21082802.
10
Isoform-Selective KCNA1 Potassium Channel Openers Built from Glycine.由甘氨酸构建的同工型选择性 KCNA1 钾通道开放剂。
J Pharmacol Exp Ther. 2020 Jun;373(3):391-401. doi: 10.1124/jpet.119.264507. Epub 2020 Mar 26.